Home
Search
Events

BIO Patient Advocacy Summit

Oct 28-29, 2020・Washington, DC

About the BIO Patient & Health Advocacy Summit

The BIO Patient and Health Advocacy Summit brings together patient advocacy organizations, academia, regulators, biotechnology industry, and other stakeholders for two days of robust programming to discuss timely policy issues and share best practices. The Summit also provides invaluable networking opportunities to advance partnership among stakeholders in the healthcare ecosystem. The Summit convenes more than 320 attendees from over 200 organizations.

Save the date for the 2020 BIO Patient and Health Advocacy Summit! 

October 25-26, 2020

Washington, DC.

View the 2019 Event Recap
2019PHAS-Photos-1
PHAS2019-Photos-2
#BIOSummit19 Concludes with Message of Hope Offered by Innovation
FDA Discusses Effective Patient Engagement at #BIOSummit19
PHAS2019-Photos-3
View the 2019 Onsite Guide

The BIO Patient & Health Advocacy Summit is a very powerful intersection of pharma, biotech, and advocacy. The exchange of challenges, ideas, concerns, and opportunities at this BIO conferences is a very powerful force in refining the perspectives, thinking, and impacting future plans of those attending. The setting is modest in size allowing not just for superficial networking, rather there is time and space for in depth conversation and follow-up.
Dean Suhr
President, MLD Foundation
Blog Posts
Browse all Blogs
Patient at Pharmacy
CMS’s Own Data Do NOT Support Claims on Part B Drug Spending
November 12, 2019
In a story entitled, “CMS Blames Medicare Part B Hikes on Drug Costs,” writers for Politico Pulse note: “The agency [Centers for Medicare & Medicaid Services] on Friday announced a $9 monthly premium increase and …
U.S. Capitol Dome
In Speaker Pelosi’s Extreme Drug Pricing Bill, Funding for NIH is MIA
November 7, 2019
Supporters of Speaker Pelosi’s extreme drug pricing bill (H.R. 3) want us to believe that they can destroy the biopharmaceutical industry and still produce new cures and treatments for patients in need. The crux of this…
Prescription Doctor
The Pelosi Plan and "Me Too" Drugs
November 5, 2019
Supporters of Speaker Pelosi’s drug pricing plan (H.R. 3) claim the bill will discourage the development of so-called “me too” drugs. For example, Rep. Donna Shalala was recently quoted as saying:  “I think it…

Thank You to Our 2019 Sponsors